BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12220533)

  • 1. CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline Cepsilon transcription in a human B cell line.
    Basaki Y; Ikizawa K; Kajiwara K; Yanagihara Y
    Arch Biochem Biophys; 2002 Sep; 405(2):199-204. PubMed ID: 12220533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
    Pearson LL; Castle BE; Kehry MR
    Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
    Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
    Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-kappaB.
    Yanagihara Y; Basaki Y; Kajiwara K; Ikizawa K
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S33-8. PubMed ID: 9440542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase/stress-activated protein kinase activation through the germinal center kinase pathway.
    Chin AI; Shu J; Shan Shi C; Yao Z; Kehrl JH; Cheng G
    Mol Cell Biol; 1999 Oct; 19(10):6665-72. PubMed ID: 10490605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
    Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
    J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.
    Hostager BS; Haxhinasto SA; Rowland SL; Bishop GA
    J Biol Chem; 2003 Nov; 278(46):45382-90. PubMed ID: 12958312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-mediated activation of Ig-Cgamma1- and Ig-cepsilon germ-line promoters involves multiple TRAF family proteins.
    Leo E; Zapata JM; Reed JC
    Eur J Immunol; 1999 Dec; 29(12):3908-13. PubMed ID: 10601998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production.
    Gauchat JF; Aversa G; Gascan H; de Vries JE
    Int Immunol; 1992 Mar; 4(3):397-406. PubMed ID: 1373645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40-mediated p38 mitogen-activated protein kinase activation is required for immunoglobulin class switch recombination to IgE.
    Zhang K; Zhang L; Zhu D; Bae D; Nel A; Saxon A
    J Allergy Clin Immunol; 2002 Sep; 110(3):421-8. PubMed ID: 12209089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
    Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
    J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel interaction between protein kinase D and TNF receptor-associated factor molecules regulates B cell receptor-CD40 synergy.
    Haxhinasto SA; Bishop GA
    J Immunol; 2003 Nov; 171(9):4655-62. PubMed ID: 14568940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination.
    Linehan LA; Warren WD; Thompson PA; Grusby MJ; Berton MT
    J Immunol; 1998 Jul; 161(1):302-10. PubMed ID: 9647237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of IL-4 receptor up-regulation on B cells by antisense oligodeoxynucleotide suppresses IL-4-induced human IgE production.
    Ikizawa K; Kajiwara K; Koshio T; Matsuura N; Yanagihara Y
    Clin Exp Immunol; 1995 Jun; 100(3):383-9. PubMed ID: 7539723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
    Sutherland CL; Krebs DL; Gold MR
    J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphotoxin-alpha is an important autocrine factor for CD40 + interleukin-4-mediated B-cell activation in normal and atopic donors.
    Worm M; Ebermayer K; Henz B
    Immunology; 1998 Jul; 94(3):395-402. PubMed ID: 9767423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TLR7 agonist imiquimod selectively inhibits IL-4-induced IgE production by suppressing IgG1/IgE class switching and germline ε transcription through the induction of BCL6 expression in B cells.
    Yoon HK; Shim YS; Kim PH; Park SR
    Cell Immunol; 2019 Apr; 338():1-8. PubMed ID: 30850088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.